Genotype-phenotype analysis of a rare type of osteogenesis imperfecta in four Chinese families with WNT1 mutations

被引:20
作者
Liu, Yi [1 ]
Song, Lijie [2 ,3 ]
Ma, Doudou [1 ]
Lv, Fang [1 ]
Xu, Xiaojie [1 ]
Wang, Jianyi [1 ]
Xia, Weibo [1 ]
Jiang, Yan [1 ]
Wang, Ou [1 ]
Song, Yuwen [1 ]
Xing, Xiaoping [1 ]
Asan [2 ,3 ]
Li, Mei [1 ]
机构
[1] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Minist Hlth, Dept Endocrinol,Key Lab Endocrinol, Beijing 100730, Peoples R China
[2] BGI Shenzhen, BGI Tianjin, BGI Shenzhen Binhai Genom Inst, Tianjin 300308, Peoples R China
[3] BGI Tianjin, Tianjin Translat Genom Ctr, Tianjin 300308, Peoples R China
基金
中国国家自然科学基金;
关键词
Osteogenesis imperfecta; Next generation sequencing; WNT1; SCLEROSTIN ANTIBODY TREATMENT; RECEPTOR-RELATED PROTEIN-5; DELETION MUTATION; MOUSE MODEL; OSTEOPOROSIS; DISEASE; PATIENT; TMEM38B; FORMS;
D O I
10.1016/j.cca.2016.07.012
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Backgrounds: Osteogenesis imperfecta (OI) is a rare inherited disease characterized by increased bone fragility and vulnerability to fractures. Recently, WNT1 is identified as a new candidate gene for OI, here we detect pathogenic mutations in WNT1 and analyze the genotype-phenotype association in four Chinese families with OI. Methods: We designed a targeted next generation sequencing panel with known fourteen OI-related genes. We applied the approach to detect pathogenic mutations in OI patients and confirmed the mutations with Sanger sequencing and cosegregation analysis. Clinical fractures, bone mineral density (BMD) and the other clinical manifestations were evaluated. We also observed the effects of bisphosphonates in 01 patients with WNT1 mutations. Results: Four compound heterozygous mutations (c.110T > C; c.505 G > T; c385G > A; c.506 G > A) in WNT1 were detected in three unrelated families. These four mutations had not been reported yet. A recurrent homozygous mutation (c.506dupG) was identified in the other two families. These patients had moderate to severe 01, white to blue sclera, absence of dentinogenesis imperfecta and no brain malformation. We did not observe clear genotype-phenotype correlation in WNT1 mutated OI patients. Though bisphosphonates increased BMD in WNT1 related OI patients, height did not increase and fracture continued. Conclusions: We reported four novel heterozygous variants and confirmed a previous reported WNT1 mutation in four Chinese families with a clinical diagnosis of OI. Our study expanded 01 spectrum and confirmed moderate to severe bone fragility induced by WNT1 defects. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:172 / 180
页数:9
相关论文
共 43 条
[1]   Variable brain phenotype primarily affects the brainstem and cerebellum in patients with osteogenesis imperfecta caused by recessive WNT1 mutations [J].
Aldinger, Kimberly A. ;
Mendelsohn, Nancy J. ;
Chung, Brian H. Y. ;
Zhang, Wenjuan ;
Cohn, Daniel H. ;
Fernandez, Bridget ;
Alkuraya, Fowzan S. ;
Dobyns, William B. ;
Curry, Cynthia J. .
JOURNAL OF MEDICAL GENETICS, 2016, 53 (06) :427-U85
[2]   Lack of Cyclophilin B in Osteogenesis Imperfecta with Normal Collagen Folding [J].
Barnes, Aileen M. ;
Carter, Erin M. ;
Cabral, Wayne A. ;
Weis, MaryAnn ;
Chang, Weizhong ;
Makareeva, Elena ;
Leikin, Sergey ;
Rotimi, Charles N. ;
Eyre, David R. ;
Raggio, Cathleen L. ;
Marini, Joan C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (06) :521-528
[3]   WNT signaling in bone homeostasis and disease: from human mutations to treatments [J].
Baron, Roland ;
Kneissel, Michaela .
NATURE MEDICINE, 2013, 19 (02) :179-192
[4]   Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta [J].
Cabral, Wayne A. ;
Chang, Weizhong ;
Barnes, Aileen M. ;
Weis, MaryAnn ;
Scott, Melissa A. ;
Leikin, Sergey ;
Makareeva, Elena ;
Kuznetsova, Natalia V. ;
Rosenbaum, Kenneth N. ;
Tifft, Cynthia J. ;
Bulas, Dorothy I. ;
Kozma, Chahira ;
Smith, Peter A. ;
Eyre, David R. ;
Marini, Joan C. .
NATURE GENETICS, 2007, 39 (03) :359-365
[5]   Wnt Signaling from Development to Disease: Insights from Model Systems [J].
Cadigan, Ken M. ;
Peifer, Mark .
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2009, 1 (02) :a002881
[6]   Wnt signalling in osteoporosis: mechanisms and novel therapeutic approaches [J].
Canalis, Ernesto .
NATURE REVIEWS ENDOCRINOLOGY, 2013, 9 (10) :575-583
[7]   Wnt/β-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis [J].
Day, TF ;
Guo, XZ ;
Garrett-Beal, L ;
Yang, YZ .
DEVELOPMENTAL CELL, 2005, 8 (05) :739-750
[8]   Mutations in WNT1 are a cause of osteogenesis imperfecta [J].
Fahiminiya, Somayyeh ;
Majewski, Jacek ;
Mort, John ;
Moffatt, Pierre ;
Glorieux, Francis H. ;
Rauch, Frank .
JOURNAL OF MEDICAL GENETICS, 2013, 50 (05) :345-348
[9]   WNT1 mutation with recessive osteogenesis imperfecta and profound neurological phenotype [J].
Faqeih, Eissa ;
Shaheen, Ranad ;
Alkuraya, Fowzan S. .
JOURNAL OF MEDICAL GENETICS, 2013, 50 (07) :491-492
[10]   Osteogenesis imperfecta [J].
Forlino, Antonella ;
Marini, Joan C. .
LANCET, 2016, 387 (10028) :1657-1671